New blood marker may help track ankylosing spondylitis activity
NCT ID NCT07383805
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will check if a protein called Tim-3 on certain white blood cells (neutrophils) is linked to disease activity in people with ankylosing spondylitis. Researchers will measure Tim-3 levels and compare them with inflammation markers and MRI scans of the hip and sacroiliac joints. The goal is to see if Tim-3 could be a useful indicator for monitoring the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a new blood test to better monitor disease activity in ankylosing spondylitis patients.
- What could go wrong
- This is an early observational study, not a treatment trial. It may not find a clear link, and results may not change current care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assiut university
Asyut, University, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Could a simple protein test unlock the secrets of joint disease?
- Can a biologic drug safely tame Back-Joint inflammation? a Real-World trial investigates
- New antibody aims to calm ankylosing spondylitis
- Can a 4-Minute chat rival a Dietitian's hour for heart health?
- Ultrasound and EMG may tell inflammatory from mechanical shoulder issues